Glutamate-based therapeutic approaches: inhibitors of glycine transport
SM Lechner - Current opinion in pharmacology, 2006 - Elsevier
A growing body of evidence suggests that activation of the glutamatergic system, particularly
N-methyl-d-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
N-methyl-d-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
Glutamate-based therapeutic approaches: inhibitors of glycine transport
SM Lechner - Current opinion in pharmacology, 2006 - pubmed.ncbi.nlm.nih.gov
A growing body of evidence suggests that activation of the glutamatergic system, particularly
N-methyl-D-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
N-methyl-D-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
Glutamate-based therapeutic approaches: inhibitors of glycine transport
SM Lechner - Current Opinion in Pharmacology, 2006 - infona.pl
A growing body of evidence suggests that activation of the glutamatergic system, particularly
N-methyl-d-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
N-methyl-d-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
[引用][C] Glutamate-based therapeutic approaches: inhibitors of glycine transport
S LECHNER - Current Opinion in Pharmacology, 2006 - cir.nii.ac.jp
Glutamate-based therapeutic approaches: inhibitors of glycine transport | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Glutamate-based therapeutic approaches: inhibitors of glycine transport.
SM Lechner - Current Opinion in Pharmacology, 2005 - europepmc.org
A growing body of evidence suggests that activation of the glutamatergic system, particularly
N-methyl-D-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
N-methyl-D-aspartate (NMDA) receptor function, may be a viable approach to the treatment …